Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis

MLA

Liang, Xinyun, et al. “Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis.” Progress in Transplantation, vol. 28, no. 2, June 2018, pp. 124–33. EBSCOhost, https://doi.org/10.1177/1526924818765798.

APA

Liang, X., Famure, O., Li, Y., & Kim, S. J. (2018). Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis. Progress in Transplantation, 28(2), 124–133. https://doi.org/10.1177/1526924818765798

Chicago

Liang, Xinyun, Olusegun Famure, Yanhong Li, and S. Joseph Kim. 2018. “Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis.” Progress in Transplantation 28 (2): 124–33. doi:10.1177/1526924818765798.